| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |